MediciNova, Inc. operates as a biopharmaceutical company. The company focuses on developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market.
The company's st…
Analysis
Hope premium
MediciNova, Inc. is priced well ahead of what the underlying numbers justify, a pattern we describe as a hope premium. Worth noting: the cash the business generates has lagged behind what the income statement shows.
Valuation data is not available for this company.
Growth is moderate; the safety picture is stretched. The company scores 6/20 on our value-creation score: not creating value.
Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Mar 20268
1
2026
All-time high
8
Mar 2026
All-time low
1
Jun 2026
Average rank
5
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
22
—
—
—
Price/Earnings
54
—
—
—
Price/Book
51
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
20
—
—
—
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.